Meta-Analysis of Randomized Controlled Trials on the Treatment of Pulmonary Arterial Hypertension

To validate the right ventricular outflow tract systolic flow acceleration (RVOTACC; peak flow velocity/time-to-peak velocity) measured by phase-contrast (PC)-cardiovascular magnetic resonance (CMR) as a novel index of right ventricular (RV) function, and to investigate its clinical implications in patients with pulmonary arterial hypertension (PAH). Thirty (38% male, 43 ± 15 years old) out of 55 consecutive patients who were initially diagnosed with PAH at the referral center were prospectively enrolled between March 2009 and July 2010 and were followed for PAH-related cardiovascular events for 2 years. The invasively measured maximum dP/dt (dP/dtmax) was used as an index of RV contractility. The PC-CMR-derived RVOTACC was compared with well-known prognostic parameters. The PC-CMR-derived RVOTACC correlated strongly with the dP/dtmax and estimated RV function more accurately than the CMR-derived RV ejection fraction. The CMR-derived RVOTACC level (HR = 0.87, 95% CI 0.78-0.98, p = 0.038) could be another powerful prognostic index compared with the functional capacity (hazard ratio [HR] = 0.88, 95% confidence interval [CI] 0.78-0.97, p = 0.035) and REVEAL Registry risk score (HR = 0.83, CI 0.56-0.95, p = 0.012). Furthermore, receiver-operating characteristic analysis identified ≥0.4 m/s2 as the optimal RVOTACC cut-off for predicting subsequent cardiovascular events. PC-CMR-derived RVOTACC is a promising non-invasively measured index of RV function and prognosis in patients with PAH.

show abstract

Cardiac magnetic resonance-derived right ventricular outflow tract systolic flow acceleration: a novel index of right ventricular function and prognosis in patients with pulmonary arterial hypertension

Kang

Chang

Yoo

et al. 2013

Int J Cardiovasc Imaging

View full text Add to dashboard Cite

show abstract

Cardiac Magnetic Resonance Imaging-Derived Pulmonary Artery Distensibility Index Correlates With Pulmonary Artery Stiffness and Predicts Functional Capacity in Patients With Pulmonary Arterial Hypertension

Kang

Chang

Kim

et al. 2011

Circ J

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Meta-Analysis of Randomized Controlled Trials on the Treatment of Pulmonary Arterial Hypertension

Cited by 2 publications

References 7 publications

Cardiac magnetic resonance-derived right ventricular outflow tract systolic flow acceleration: a novel index of right ventricular function and prognosis in patients with pulmonary arterial hypertension

Cardiac magnetic resonance-derived right ventricular outflow tract systolic flow acceleration: a novel index of right ventricular function and prognosis in patients with pulmonary arterial hypertension

Cardiac Magnetic Resonance Imaging-Derived Pulmonary Artery Distensibility Index Correlates With Pulmonary Artery Stiffness and Predicts Functional Capacity in Patients With Pulmonary Arterial Hypertension

Contact Info

Product

Resources

About